GlassScriptPhysician profile
Candace A Becker
NPI 1982930202
$5,405.58
in general payments reported to CMS, 2019-2025
17 companies · $2,819 in 2025
The $2,819 reported for 2025 was more than what 95% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.50 · 2022: $1,674 · 2023: $201 · 2024: $657 · 2025: $2,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592 · Travel and Lodging: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.53 |
| Travel and Lodging | $1,084.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,904.28 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $1,485.86 | 2022 | |
| Novo Nordisk INC | $314.28 | 2024-2025 | Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $305.88 | 2021-2025 | Lifevest |
| Amgen INC. | $274.21 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $180.65 | 2024-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $176.32 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Endologix LLC | $173.06 | 2025 | Torus Stent Graft System, Endocross Device |
| Edwards Lifesciences Corporation | $148.08 | 2025 | |
| Xeris Pharmaceuticals, INC. | $121.83 | 2025 | Gvoke Hypopen |
| Medtronic, INC. | $105.51 | 2024 | Aurora Ev-Icd Mri Surescan |
| Merck Sharp & Dohme LLC | $58.27 | 2022-2025 | Verquvo, Belsomra |
| Kestra Medical Technology Services, INC. | $51.69 | 2023-2024 | Assure Wcd |
| Acera Surgical, INC. | $37.74 | 2021 | |
| Daiichi Sankyo INC. | $24.36 | 2024 | Injectafer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $24.19 | 2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $19.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.